Difficulty: Medium
Average Score: 63%
Practice
Leishmania donovani is susceptible to certain antifungal drugs because both fungi and Leishmania
Correct answer
D
Rationale
The correct answer is D) Have ergosterol in their cell membranes.
Leishmania donovani, a protozoan parasite causing leishmaniasis, is susceptible to certain antifungal drugs that target ergosterol in the cell membrane. Ergosterol is a sterol found in fungal cell membranes, and Leishmania, although not a fungus, shares a similar structure in its cell membrane composition. By targeting ergosterol, these antifungal drugs disrupt the integrity and function of the cell membrane, leading to the death of the Leishmania parasite.
Now, let's dissect why the other options are incorrect:
A) Utilize purine salvage pathway: This pathway is involved in the synthesis of purine nucleotides and is not directly related to the susceptibility of Leishmania to antifungal drugs.
B) Utilize similar glycolytic mechanisms: While both fungi and Leishmania rely on glycolysis for energy production, this similarity does not explain why Leishmania is susceptible to antifungal drugs.
C) Have similar topoisomerase II enzyme: While topoisomerase II enzymes are involved in DNA replication and are potential drug targets, this similarity does not explain the susceptibility of Leishmania to antifungal drugs.
Educational context: Understanding the mechanisms of action of antifungal drugs and their impact on different pathogens is crucial in the field of pharmacology and infectious diseases. By knowing the specific targets of these drugs, healthcare professionals can make informed decisions regarding treatment options for various infections, including leishmaniasis. This question reinforces the importance of knowing the specific targets of medications and their relevance to different pathogens.
Leishmania donovani, a protozoan parasite causing leishmaniasis, is susceptible to certain antifungal drugs that target ergosterol in the cell membrane. Ergosterol is a sterol found in fungal cell membranes, and Leishmania, although not a fungus, shares a similar structure in its cell membrane composition. By targeting ergosterol, these antifungal drugs disrupt the integrity and function of the cell membrane, leading to the death of the Leishmania parasite.
Now, let's dissect why the other options are incorrect:
A) Utilize purine salvage pathway: This pathway is involved in the synthesis of purine nucleotides and is not directly related to the susceptibility of Leishmania to antifungal drugs.
B) Utilize similar glycolytic mechanisms: While both fungi and Leishmania rely on glycolysis for energy production, this similarity does not explain why Leishmania is susceptible to antifungal drugs.
C) Have similar topoisomerase II enzyme: While topoisomerase II enzymes are involved in DNA replication and are potential drug targets, this similarity does not explain the susceptibility of Leishmania to antifungal drugs.
Educational context: Understanding the mechanisms of action of antifungal drugs and their impact on different pathogens is crucial in the field of pharmacology and infectious diseases. By knowing the specific targets of these drugs, healthcare professionals can make informed decisions regarding treatment options for various infections, including leishmaniasis. This question reinforces the importance of knowing the specific targets of medications and their relevance to different pathogens.